Osteonecrosis and Fosamax

since 2001, more than 2,400 people have been diagnosed with osteonecrosis of the jaw () after taking fosamax

Recent studies demonstrate a clear link between osteonecrosis and . The irony is that these drugs, such as , that are prescribed to prevent bone loss may actually be causing bone decay – such as ().

do you need a fosamax lawyer?

If you or a loved one have suffered serious side effects while taking , if you have been diagnosed with osteonecrosis, or if you are experiencing the symptoms asscociated with , you may have a claim against the manufacturer of .

Please contact us today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost no-obligation evaluation of your case.

Latest News

FDA review shows no link between bone treatment and thigh fractures

tabletsThe Food and Drug Administration (FDA) says data from an ongoing safety review of oral bisphosphonates, such as Fosamax, prescribed for the treatment of bone loss, do not appear to be related to an increased risk of thigh fractures. However, the agency is telling health care professionals to be aware of a possible risk of atypical subtrochanteric femur fractures in patients using bisphosphonates.

The ongoing safety review was initiated in June 2008, following published case reports of this specific type of thigh fracture in patients with osteoporosis taking bisphosphonates. The agency says it will continue to study this issue along with a team of outside experts, which includes members of the American Society of Bone and Mineral Research Subtrochanteric Femoral Fracture Task Force.

Read the rest of this entry »

Beasley Allen attorney files lawsuit against maker of Fosamax

tabletsThree lawsuits against the makers of Fosamax, a popular medication to prevent bone loss, are slated to go to trial, including one filed in Alabama state court by Beasley Allen attorney W. Chad Cook. The lawsuits are among the nearly 900 cases brought against & Co. by 1,280 plaintiff groups who allege caused them serious jaw problems.

Read the rest of this entry »

Merck paid publisher to print positive stories about Vioxx, Fosamax

medjournal 100x100A science and health publisher says years ago it published what appeared to be medical journals for a group of Australian doctors that heavily favored and Co.’s drugs Fosamax and Vioxx. The journals didn’t list who paid for the publishing, when in fact the publications were sponsored by .

Read the rest of this entry »